Sign in

You're signed outSign in or to get full access.

Christine M. Riordan

Director at RE/MAX Holdings
Board

About Christine M. Riordan

Christine M. Riordan, Ph.D., is an independent director of RE/MAX Holdings and President of Adelphi University. She is age 60 and has served on the RMAX board since 2015, bringing deep expertise in leadership, talent development, strategy, and team performance; she is also a NACD Board Leadership Fellow . The Board has affirmatively determined she is independent under NYSE standards .

Past Roles

OrganizationRoleTenureCommittees/Impact
Adelphi UniversityPresidentNot disclosedCEO-level leadership; strategy and organizational performance expertise
Executive coaching across industriesExecutive coach/program designerNot disclosedLeadership development; career success; team performance

External Roles

OrganizationRoleTenureNotes
Commission for Independent Colleges and UniversitiesDirectorNot disclosedBoard service in higher education
Adelphi UniversityTrusteeNot disclosedUniversity governance oversight
NACDBoard Leadership FellowNot disclosedOngoing director education and credentials

Board Governance

  • Committees: Chair of Nominating & Corporate Governance; Member of Compensation .
  • Meetings: Audit (7), Compensation (4), Nominating & Corporate Governance (4) in 2024; Board met 6 times; all directors attended 100% of Board and committee meetings in 2024 .
  • Independence: Determined independent under NYSE standards .
  • Annual meeting: All directors attended 2024 annual meeting .
  • Structure: Separate Chair and CEO; formal Lead Independent Director role; independent directors meet without management; Board and committees fully independent .

Fixed Compensation

Component (Directors)Amount ($)Notes
Base retainer80,000Cash
Nominating & Corporate Governance Chair retainer15,000Cash
Compensation Committee member retainer6,000Cash
Annual equity grant (RSUs)100,000RSUs vest after ~1 year
Dividend equivalents paid on vested RSUs (FY2024)1,244Cash
Total FY2024 compensation (Riordan)202,247Fees earned in cash: 101,000; Stock awards: 100,003; Other: 1,244

Performance Compensation

ItemDetail
Performance-based awardsNone disclosed for directors; annual RSU grants are time-based
OptionsNone disclosed for directors in 2024

Other Directorships & Interlocks

CategoryDetail
Current public company boardsNone disclosed for Dr. Riordan
Non-profit/academic boardsCommission for Independent Colleges and Universities (director); Adelphi University (Trustee)
Compensation committee interlocksNone for any members; no Item 404 relationships; no interlocks existed

Expertise & Qualifications

  • Leadership, strategy, talent development, and team performance; executive coaching across industries .
  • Board governance: NACD Board Leadership Fellow; commitment to ongoing director education; Board conducts annual self-evaluations .
  • Broad business exposure including financial services, insurance, real estate, mortgage, franchised businesses, and higher education .

Equity Ownership

MeasureValueNotes
Beneficial ownership (Class A shares)35,598As of record date; “Less than 1%” in proxy table
Unvested RSUs outstanding (12/31/2024)11,364Vests May 1, 2025
Shares outstanding (Class A)19,906,921As of record date
Ownership as % of shares outstanding~0.18%Computed from 35,598 / 19,906,921
Stock ownership guidelines3x base cash retainer for non-employee directorsOwnership counted includes beneficial shares and unvested time-based RSUs (with conditions)
Indicative alignment vs guidelineBase retainer $80k → 3x = $240k; 35,598 shares × $10.67 = ~$379k (Dec 31, 2024 close)Suggests guideline met based on disclosed price and share count

Anti-hedging/pledging: Insider Trading Policy prohibits hedging or pledging without prior Board consent; no consents have been granted .

Governance Assessment

  • Board effectiveness: Riordan chairs Nominating & Corporate Governance and serves on Compensation, with 100% attendance—indicates strong engagement and governance influence .
  • Independence and risk controls: Independent director; independent committees; clawback policy and compensation risk assessment in place; independent compensation consultant (Meridian) used by the Compensation Committee .
  • Ownership alignment: Significant personal holding and unvested RSUs; non-employee director ownership guideline of 3x cash retainer likely met based on disclosed share count and price .
  • Conflicts: No related-party transactions disclosed for Riordan; compensation committee interlocks and Item 404 relationships explicitly none for committee members .
  • Investor engagement signals: Company conducted outreach to holders representing ~40% of Class A shares and met with ~30%; Board maintains independent Lead Director and separate Chair/CEO .
  • Potential red flags (contextual, not director-specific): Classified board; concentrated voting power—RIHI, controlled by David and Gail Liniger, held ~38.73% combined voting power as of record date, which can limit minority shareholder influence .